FDA Brief

Warning letters Food

FDA warning letter to

Healthy Trends Worldwide, LLC

LowIssued Nov 14, 2022Posted Nov 17, 2022Center for Food Safety and Applied Nutrition (CFSAN)

Healthy Trends Worldwide markets BPS-5 supplement with blood-pressure drug claims, FDA says.

What happened

FDA reviewed the company’s website in October 2022 and its Facebook and YouTube pages, which direct consumers to the website to buy BPS-5. FDA found claims that BPS-5 regulates blood pressure and that its ingredients fight blood pressure, blood disorders, and heart disease. FDA says these claims make BPS-5 a drug, and that it is an unapproved new drug and misbranded.

What FDA found

  1. The website and social media claims show BPS-5 is intended to treat or prevent disease, so FDA treats it as a drug.

    section 201(g)(1)(B) of the Act [21 U.S.C. 321(g)(1)(B)]
  2. BPS-5 is not generally recognized as safe and effective for these uses, making it an unapproved new drug.

    section 201(p) of the Act [21 U.S.C. 321(p)]; sections 301(d) and 505(a) [21 U.S.C. 331(d), 355(a)]
  3. The product lacks adequate directions for safe use by a layperson for its intended use.

    section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]; 21 CFR 201.5
  4. Selling the misbranded drug in interstate commerce violates the Act.

    section 301(a) of the Act [21 U.S.C. 331(a)]

What FDA wants

FDA asks the company to notify it in writing within 15 working days of steps taken to correct the violations, including how it will prevent recurrence and related documentation.

Who should pay attention

  • dietary supplement brands that make blood-pressure claims
  • online marketers and affiliates promoting supplements
  • companies selling disease-treatment claims for supplements

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk